Hostname: page-component-848d4c4894-wg55d Total loading time: 0 Render date: 2024-05-14T12:55:13.967Z Has data issue: false hasContentIssue false

LTD4 is involved in the control of non-differentiated intestinal epithelial cell growth

Published online by Cambridge University Press:  19 April 2013

M. Cabral
Affiliation:
Departament de Fisiologia, Facultat de Farmàcia, Universitat de Barcelona
J. J. Moreno
Affiliation:
Departament de Fisiologia, Facultat de Farmàcia, Universitat de Barcelona
R. Martín-Venegas
Affiliation:
Departament de Fisiologia, Facultat de Farmàcia, Universitat de Barcelona
Rights & Permissions [Opens in a new window]

Abstract

Type
Abstract
Copyright
Copyright © The Authors 2013 

Leukotriene D4 (LTD4) is a powerful pro-inflammatory mediator, which is formed from arachidonic acid through 5-lipoxygenase (5-LOX). LTD4 mediates its effects through two specific cell surface receptors, CysLT1R and CysLT2R( Reference Heise, O'Dowd and Figueroa 1 ). Colon tumours have an increased expression of CysLT1R and it has recently been observed that colon cancer patients with high expression levels of this receptor have poor prognosis( Reference Magnusson, Mezhybovska and Lörinc 2 ).

The aim of this study was to investigate the potential role of LTD4 on the control of non-differentiated intestinal epithelial cell growth using intestinal human Caco-2 cells (HTB37, ATCC) in culture.

We observed that LTD4 (1–100 nM) induces Caco-2 cell proliferation in a concentration dependent manner. Moreover, cell growth and DNA synthesis induced by LTD4 were reverted by specific CysLT1R antagonists, such as MK571 and LY171883, thus indicating the involvement of this receptor in these events.

Considering that LTD4 up-regulates 5-LOX, cyclooxigenase 2 (COX-2) and CysLT1R levels in intestinal epithelial cells( Reference Yudina, Parhamifar, Bengtsson, Juhas and Sjölander 3 ), we study the role of COX pathway on the effect of LTD4 on Caco-2 cell growth. Our findings show that LTD4 induces PGE2 synthesis in Caco-2 cell cultures. Moreover, ketoprofen, a COX inhibitor, NS398, a specific COX-2 inhibitor, and SC560, a specific COX-1 inhibitor, were able to inhibit Caco-2 cell growth and DNA synthesis induced by LTD4. Furthermore, similar effects were obtained using antagonists of PGE2 receptor, such as SC19220, a specific EP1 antagonist, and AH23838, a specific EP4 antagonist.

These data suggest that the proliferative effect of LTD4 is dependent on PGE2 synthetized by both COXs and on PGE2 interaction with EP1 and EP4 receptors. Finally, we provide evidence that LTD4 stimulates several cell signalling pathways involved in cell growth, such as ERK, β-catenin, CREB, and p38α.

On the basis of our results we can conclude that LTD4 is involved in the regulation of Caco-2 cell growth through the interaction of CysLT1R and the subsequent PGE2 synthesis and cell signaling pathways activation. It is hoped that these findings show novel mechanisms by which the effect of LTD4 on intestinal epithelial cell growth may be mediated.

Supported by Ministerio de Ciencia e Innovación (BFU2007–61727/BFI) and Generalitat de Catalunya (2009SGR0438).

References

1. Heise, CE, O'Dowd, BF, Figueroa, DJ et al. (2000) J Biol Chem 275, 3053130536.CrossRefGoogle Scholar
2. Magnusson, C, Mezhybovska, M, Lörinc, E et al. (2010) Eur J Cancer 46, 826835.Google Scholar
3. Yudina, Y, Parhamifar, L, Bengtsson, AM, Juhas, M, Sjölander, A. (2008) Prostaglandins Leukot Essent Fatty Acids 79, 223231.Google Scholar